Clinical Trial Update: PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II investigator-initiated trial evaluating the safety and efficacy of ripasudil in retinopathy of prematurity has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• Ripasudil (Ripasudil)

Snippet

Sponsor: Kyushu University | Conditions: Retinopathy of Prematurity | Phase 1, Phase 2 | Status: COMPLETED